Luminex Gets FDA OK for Second-Generation CF Test | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex announced after the market closed Thursday that it has received US Food and Drug Administration clearance for its second-generation cystic fibrosis test.

The xTAG Cystic Fibrosis 39 Kit v2 detects 39 CF-causing gene mutations. It is used to screen potential parents to determine if they are carriers of the CF-causing gene mutations, and also can be used as an aid in newborn screening and in confirmatory diagnostic testing in newborns and children, said Luminex.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.